Udayavni Special

Bharat Biotech’s US partner Ocugen submits ‘Master File’ to FDA on Covaxin


PTI, May 25, 2021, 1:03 PM IST

New Delhi: Ocugen, Bharat Biotech’s American partner for Covid-19 vaccine Covaxin, has submitted a “Master File” to the US Food and Drug Administration prior to seeking an emergency use authorisation in that country. “The company is currently evaluating the clinical and regulatory path for Covaxin in the United States including obtaining Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA).

Also, eventually biologic license application (BLA) approval in the United States, as well as the company’s commercialization strategy, if authorized or approved,” Ocugen has said in a recent regulatory filing. Ocugen has submitted key information and data to date including preclinical studies, chemistry, manufacturing, and controls (CMC), and clinical studies as a Master File for FDA review and input prior to a planned EUA submission.

The company is currently awaiting additional data from Bharat Biotech from the ongoing Phase 3 clinical trial for a EUA submission, it further said. Bharat Biotech on February 2 said it has entered into a definitive agreement with OcugenInc, a US-based biopharmaceutical company, to co-develop, supply, and commercialise, the Indian vaccine maker’s Covaxin for the US market.

Under the terms of the agreement, Ocugen will have US rights to the vaccine candidate and will be responsible for clinical development, regulatory approval including Emergency Use Authorisation and commercialization for the US market. The Indian government’s temporary suspension of the export of Covid-19 vaccines may require Bharat Biotech to focus its resources, including Covaxin supply, on domestic requirements and thereby prevent it from shipping supply of the vaccines abroad, including to the United States, the American company said in the risk factors.

“We are currently waiting for additional data from Bharat Biotech from the ongoing Phase 3 clinical trial for an EUA submission. Due to the current surge in Covid-19 cases in India, this process is taking longer than anticipated.

We are continuing to monitor the situation and intend to file the EUA submission as soon as practicable. Any significant delays could adversely affect our business, results of operations, or financial condition,” Ocugen said.

In an investor presentation, Ocugen said it is expecting the vaccine to be rolled out in the US during the second half of the current year. The initial US supply will be done by Bharat Biotech upon receiving authorisation from the FDA and also there will be technology transfer to US facilities. Ocugen is targeting 100 million doses per annum beginning 2021.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Assess if physical classes can be held for students of classes 10 and 12 in COVID-free villages: Maha CM

2 more Cong MLAs back Siddaramaiah as CM candidate in next assembly election

Complete pending road works soon: Udupi DC Jagadeesh directs NH officials

B’luru-based firm launches helpline for COVID related legal queries

‘Jal Jeevan Mission’: Govt to provide tap water connection to 25 lakh rural households this year

Sitharaman meets Infosys officials, reviews tech glitches on new I-T e-filing portal

SC refuses to interfere with CBSE, CISCE assessment scheme for evaluating Class 12 students



Related Articles More

IIT-B scientist gets DCGI nod to launch algo-based COVID-19 testing tool

COVID effect: Confidence levels of working women, young professionals lowest amongst workforce

Is Covid wave 2 over? Positivity rate below 5 pc for 15 days, but experts say end still far

Third wave? 350 children test Covid positive every week in Mysuru

COVID-19: 4,867 new cases including 542 in DK, 142 deaths in Karnataka

MUST WATCH

Karnataka Covid-19 Unlock

Jayalaxmi Silks Udyavara | Premium Chiffon Sarees

Massive Landslide in Chorla Ghat

Forest Department personnel responsible for cattle smuggling

All shops permitted to open from June 23 in Dakshina Kannada: Kota Poojary

Latest Additions

Assess if physical classes can be held for students of classes 10 and 12 in COVID-free villages: Maha CM

West Bengal budget session to begin from July 2

2 more Cong MLAs back Siddaramaiah as CM candidate in next assembly election

Complete pending road works soon: Udupi DC Jagadeesh directs NH officials

Power lunch: Adityanath, RSS leaders meet at Dy CM Maurya’s home

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.